Tower Research Capital (TRC)’s Tiziana Life Sciences TLSA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-153	Closed	-$106	–	5783
2024 Q4	$106	Sell	153 -275	-64%	-$254	﹤0.01%	5463
2024 Q3	$411	Buy	+428	New	+$432	﹤0.01%	5347
2023 Q3	–	Sell	-17,844	Closed	-$12.2K	–	6232
2023 Q2	$12.2K	Buy	17,844 +6,168	+53%	+$5.22K	﹤0.01%	3898
2023 Q1	$13K	Sell	11,676 -4,454	-28%	-$2.91K	﹤0.01%	4013
2022 Q4	$10K	Buy	16,130 +761	+5%	+$505	﹤0.01%	4082
2022 Q3	$12K	Buy	15,369 +9,410	+158%	+$7.09K	﹤0.01%	4375
2022 Q2	$4K	Buy	5,959 +3,206	+116%	+$2.76K	﹤0.01%	5257
2022 Q1	$3K	Sell	2,753 -4,916	-64%	-$4.35K	﹤0.01%	5422
2021 Q4	$7K	Buy	+7,669	New	+$10.2K	﹤0.01%	4950
2019 Q3	–	Sell	-400	Closed	-$1K	–	4507
2019 Q2	$1K	Buy	+400	New	+$637	﹤0.01%	3492

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.95% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.52B AUM 31.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Tower Research Capital (TRC)'s TLSA Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Tiziana Life Sciences (TLSA) in Q1 2025, closing a stake of 153 shares — an estimated $106 sold.

Tower Research Capital (TRC) first reported a position in TLSA in Q2 2019 and held it in 10 quarters. The position peaked at $13K in Q1 2023. 33 funds tracked by Wall St. Rank hold TLSA as of Q1 2025.

Tower Research Capital (TRC) reported no remaining Tiziana Life Sciences position as of Q1 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 153 Tiziana Life Sciences shares in Q1 2025, an estimated $106.
Tower Research Capital (TRC) first reported a position in Tiziana Life Sciences in Q2 2019 and held it in 10 quarters.
Tower Research Capital (TRC)'s Tiziana Life Sciences position peaked at $13K in Q1 2023.
33 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.